Cartesian Therapeutics RNAC
NASDAQ RNAC
$7.21 -0.03 (-0.41%)
At close: Sep 30, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Other financing activities (2020 - 2022)

Updated

Cartesian Therapeutics' Other financing activities was $110,000 in FY2022.

Analysis

Cartesian Therapeutics (RNAC) Other financing activities (2020 - 2022) Analysis & Trends

  • Per Business Quant data, Other financing activities in earlier years was $4.38 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cartesian Therapeutics 216.57 Mn 216.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 110,000.00
Mar 31, 2020 4.38 Mn
API Access

Cartesian Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=RNAC&period=max&api_key=YOUR_API_KEY